A much-anticipated home delivery service for high-cost medications begins in Greece on Monday, with some 139,000 patients suffering from chronic and serious illnesses expected to benefit from easier access to treatment.<\/p>\n
The new service \u2013 a first by a public health insurer in Europe \u2013 abolishes the need for these patients to get their medications from a handful of specialized pharmacies run by the National Organization for Public Health (EOPYY), often facing a long journey to the dispensary and queues.<\/p>\n
To use the service, patients can apply online, through a new call center (18181), or in person at EOPYY pharmacies and service points. They will need an electronic prescription and, if needed, a digital medical approval. Once the request is approved, their medications \u2013 including those requiring cold-chain handling \u2013 will be delivered within 24 to 48 hours.<\/p>\n
Prescriptions are reviewed and filled by licensed pharmacists, while delivery is managed by a certified logistics company and can be made to patients\u2019 place of work or vacation homes.<\/p>\n
To apply online, patients need to log on to www.eopyy.gov.gr. The website is in Greek only, however, so non-Greek speakers may need to ask their pharmacist for assistance. They also need to have Taxisnet credentials, a social security number (AMKA) and tax ID (AFM), while first-time users will need to verify their email and phone number.<\/p>\n
\u201cFor those unfamiliar with online systems, help desks and the 18181 line are available to assist with the application,\u201d said EOPYY President Theano Karpodini.<\/p>\n","protected":false},"excerpt":{"rendered":"A much-anticipated home delivery service for high-cost medications begins in Greece on Monday, with some 139,000 patients suffering…\n","protected":false},"author":2,"featured_media":186373,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[105,1491,4326,4678,16,15],"class_list":{"0":"post-186372","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-in-depth","10":"tag-medication","11":"tag-society","12":"tag-uk","13":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114687474970149114","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/186372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=186372"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/186372\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/186373"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=186372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=186372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=186372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}